James M. Henning, MS

home / authors / james-m-henning-ms

Articles

April 1st 2005

A Systematic Review of Diabetes Disease Management Programs

Kevin Knight, MD, MPH Enkhe Badamgarav, MD, MPH James M. Henning, MS Vic Hasselblad, PhD Anacleto D. Gano, Jr, MPH Joshua J. Ofman, MD, MSHS Scott R. Weingarten, MD, MPH

March 1st 2003

Physician Attitudes Toward Strategies to Promote the Adoption of Medical Evidence Into Clinical Practice

Jeff Borenstein, MD, MPH Chiun-Fang Chiou, PhD James M. Henning, MS Alisa Wilson, PhD Andriana A. Hohlbauch, MPH Margaret S. Richards, PhD

January 1st 2000

An Instrument to Measure Patient Satisfaction with Healthcare in an Observational Database: Results of a Validation Study Using Data from CaPSURE

Deborah P. Lubeck, PhD Mark S. Litwin, MD, MPH James M. Henning, MS Susan D. Mathias, MPH Lindsey Bloor, MS Peter R. Carroll, MD

December 1st 1998

The Role of Clinical Practice Guidelines in Disease Management

James M. Henning, MS

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Terra Wonsettler, PharmD, MBA | Image credit: LinkedIn photo

Published: December 19th 2024 | Updated: December 26th 2024

The Dangerous Intersection of Breast Cancer and Cardiovascular Disease: A Call for Improved Prevention

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions